大流行科学数据共享建议:世界卫生紧急状态结束后对预印本服务器的审视与重新构想
大流行早期预印本服务器加速了证据共享,多家主要医学期刊联合支持其使用以确保科学进展的公平获取。此后三年,COVID-19预防与治疗取得重大进展,也认识到预印本作为科学知识共享与传播机制的益处与局限。预印本增加关注度、引用并最终影响政策,常在结果验证前;证据提示预印本相对同行评议出版物有更多夸大。预印本服务器上的临床试验结果经同行评议后无实质变化,但其他研究类型(如建模和观察性研究)常经大幅修订或从未发表。作者认为需要细致的结果共享政策以平衡快速实施真实重要进展与准确性,应重新评估建议立即发布COVID-19相关研究的政策,并制定未验证研究的评估与共享标准。
要点
- 预印本增加关注度、引用并最终影响政策,常在结果验证前。
- 证据提示预印本相对同行评议出版物有更多夸大。
- 预印本服务器上的临床试验结果经同行评议后无实质变化。
- 其他研究类型(如建模和观察性研究)常经大幅修订或从未发表。
- 作者建议重新评估建议立即发布COVID-19相关研究的政策,并制定未验证研究的评估与共享标准。
研究设计与关键结果
- 制定机构与性质:本文为Antimicrob Steward Healthc Epidemiol刊载的推荐性文章,提出大流行科学数据共享建议;原文未描述系统的证据分级方法。
- 作者建议:应重新评估建议立即发布COVID-19相关研究的政策;应制定未验证研究的评估与共享标准,可能包括:预印本应包含哪些信息、特定数据质量标准要求(如对图像和表格的自动化审查)、代码发布与共享要求、将早期发布限制在方法、结果和局限性部分。
- 作者认为:学术出版需要创新和改进,但证据质量评估仍是科学发现与传播过程的关键部分。
证据类型、等级与局限
- 证据类型:推荐性文章(guideline),原文未给出证据等级或推荐强度标签。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为:应重新评估建议立即发布COVID-19相关研究的政策。
- 作者建议:应制定未验证研究的评估与共享标准,可能包括预印本应包含的信息规格、特定数据质量标准(如对图像和表格的自动化审查)、代码发布与共享要求,以及将早期发布限制在方法、结果和局限性部分。
- 作者认为:学术出版需要创新和改进,但证据质量评估仍是科学发现与传播过程的关键部分。
指南或共识出处
- 文章出处:Antimicrob Steward Healthc Epidemiol;原文未给出具体指南或共识名称及发布年份。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Early in the pandemic, pre-print servers sped rapid evidence sharing. A collaborative of major medical journals supported their use to ensure equitable access to scientific advancements. In the intervening three years, we have made major advancements in the prevention and treatment of COVID-19 and learned about the benefits and limitations of pre-prints as a mechanism for sharing and disseminating scientific knowledge. Pre-prints increase attention, citations, and ultimately impact policy, often before findings are verified. Evidence suggests that pre-prints have more spin relative to peer-reviewed publications. Clinical trial findings posted on pre-print servers do not change substantially following peer-review, but other study types (e.g., modeling and observational studies) often undergo substantial revision or are never published. Nuanced policies about sharing results are needed to balance rapid implementation of true and important advancements with accuracy. Policies recommending immediate posting of COVID-19-related research should be re-evaluated, and standards for evaluation and sharing of unverified studies should be developed. These may include specifications about what information is included in pre-prints and requirements for certain data quality standards (e.g., automated review of images and tables); requirements for code release and sharing; and limiting early postings to methods, results, and limitations sections. Academic publishing needs to innovate and improve, but assessments of evidence quality remains a critical part of the scientific discovery and dissemination process.
参考来源
- Doron S, Branch-Elliman W. Pandemic scientific data sharing recommendations: examining and re-imagining pre-print servers after the end of the world-wide emergency. Antimicrob Steward Healthc Epidemiol. 2023. PMID: 37663450. doi:10.1017/ash.2023.410
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。